Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Chlorhexidine glucon 2%/Isopropyl alcohol 70% soln 26ml
1311020L0AABZBZ
|
Chlorhexidine gluconate (Topical cleanser) | Chlorhexidine gluconate | Skin | 12 |
|
Coal tar 5% in Clobetasone 0.05% ointment
1304000H0AACHCH
|
Clobetasone butyrate (Topical) | Clobetasone butyrate | Skin | 12 |
|
Dermacolor body camouflage
130802000BBBAA0
|
Proprietary compound preparation BNF 1308020 | Other camouflage preparations | Skin | 12 |
|
Diflucortolone 0.3% ointment
1304000L0AABCBC
|
Diflucortolone valerate | Diflucortolone valerate | Skin | 12 |
|
Salicylic acid 25% in White soft paraffin
1305020S0AACJCJ
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 12 |
|
Tretinoin 0.05% cream
1306010V0AAANAN
|
Tretinoin (Acne) | Tretinoin | Skin | 12 |
|
Diflucortolone 0.1% ointment
1304000L0AABBBB
|
Diflucortolone valerate | Diflucortolone valerate | Skin | 11 |
|
Pickles 50% ointment
1307000M0BEAAAE
|
Pickles Foot | Salicylic acid | Skin | 11 |
|
Rosiced 0.75% cream
1310012K0BLAAAX
|
Rosiced | Metronidazole | Skin | 11 |
|
Sunsense toddler milk lotion SPF 50+
130801000BBMAA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | 11 |
|
Avoca 95% silver nitrate applicators
1307000Q0BBACAE
|
Avoca | Silver nitrate | Skin | 10 |
|
Daktarin 2% powder
1310020N0BBABAB
|
Daktarin (Miconazole nitrate) | Miconazole nitrate | Skin | 10 |
|
Freederm Treatment 4% gel
1306010N0BDABAA
|
Freederm | Nicotinamide | Skin | 10 |
|
Gamolen 40mg capsules
1305010I0BVAAAA
|
Gamolen | Gamolenic acid | Skin | 10 |
|
Scholl Verruca Removal System 40% medicated plasters
1307000M0BQAHBS
|
Scholl (Corn & Verruca) | Salicylic acid | Skin | 10 |
|
Synalar N ointment
1304000N0BBANCD
|
Synalar | Fluocinolone acetonide | Skin | 10 |
|
Urea 25% ointment
1302010U0AAAVAV
|
Urea (Emollient) | Urea | Skin | 10 |
|
Virasorb Cold Sore 5% cream
1310030C0BFAAAA
|
Virasorb | Aciclovir | Skin | 10 |
|
Balmonds Bath & Body Oil
130201100BBAXA0
|
Proprietary compound preparation BNF 1302011 | Emollient bath and shower preparations | Skin | 9 |
|
Coal tar 6% / Salicylic acid 1% in Emulsifying ointment
1305020C0AAFGFG
|
Coal tar/tar (Topical) | Tars | Skin | 9 |
|
Cutan Hand Sanitiser foam
131101000BMAPA0
|
Proprietary compound preparation BNF 1311010 | Other alcohol and saline preparations | Skin | 9 |
|
Dithranol 0.4% ointment
1305020F0AACWCW
|
Dithranol (Topical) | Dithranol | Skin | 9 |
|
Eucerin AntiREDNESS concealing day cream SPF25
130201000BBLPA0
|
Proprietary compound emollients | Other emollient preparations | Skin | 9 |
|
Hydrous wool fat
1301010I0AAAAAA
|
Wool fat hydrous | Wool fat hydrous | Skin | 9 |
|
Neutrogena Norwegian Formula 40% dermatological cream
130201000BBDPBX
|
Proprietary compound emollients | Other emollient preparations | Skin | 9 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.